Serum CA125 at 11-14 weeks of gestation in women with morphologically normal ovaries.
Open Access
- 1 May 2000
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 107 (5), 689-690
- https://doi.org/10.1111/j.1471-0528.2000.tb13314.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐AUltrasound in Obstetrics & Gynecology, 1999
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.BMJ, 1992
- The distribution of CA 125 in the reproductive tract of pregnant and non‐pregnant womenBJOG: An International Journal of Obstetrics and Gynaecology, 1988
- Evaluation of Serum CA125 Values in Healthy Individuals and Pregnant WomenThe American Journal of the Medical Sciences, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerThe New England Journal of Medicine, 1983